CN Stock MarketDetailed Quotes

603392 Beijing Wantai Biological Pharmacy Enterprise

Watchlist
  • 72.30
  • +2.28+3.26%
Market Closed Oct 18 15:00 CST
91.47BMarket Cap-469480P/E (TTM)

Beijing Wantai Biological Pharmacy Enterprise Key Stats

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
-67.19%1.37B
-73.93%752.51M
-50.73%5.51B
-42.56%4.97B
-29.78%4.16B
-8.98%2.89B
94.51%11.19B
140.56%8.65B
201.92%5.93B
284.85%3.17B
Operating revenue
-67.19%1.37B
-73.93%752.51M
-50.73%5.51B
-42.56%4.97B
-29.78%4.16B
-8.98%2.89B
94.51%11.19B
140.56%8.65B
201.92%5.93B
284.85%3.17B
Other operating revenue
-0.20%13.54M
----
-6.56%17.3M
----
110.02%13.57M
----
-61.69%18.52M
----
-93.43%6.46M
----
Total operating cost
-42.51%1.29B
-52.76%672.2M
-32.52%3.88B
-21.80%3.08B
-14.20%2.24B
-3.53%1.42B
68.85%5.75B
80.88%3.93B
128.51%2.61B
207.04%1.47B
Operating cost
-9.73%366.52M
-16.30%202.78M
-32.32%792.12M
-34.40%591.63M
-36.59%406.03M
-25.81%242.26M
43.13%1.17B
80.55%901.85M
120.55%640.37M
153.82%326.55M
Operating tax surcharges
-47.23%11.52M
-75.45%2.95M
-33.87%33.91M
-32.53%25.82M
-14.15%21.83M
4.28%12.01M
91.96%51.28M
149.89%38.27M
172.66%25.43M
254.97%11.52M
Operating expense
-75.36%315M
-77.58%203.52M
-50.98%1.6B
-39.91%1.51B
-21.77%1.28B
-6.98%907.65M
92.49%3.25B
132.42%2.51B
192.29%1.63B
310.14%975.78M
Administration expense
27.58%153.84M
28.03%75M
50.15%352.63M
30.92%196.63M
19.66%120.59M
20.31%58.58M
28.90%234.85M
20.02%150.19M
27.12%100.77M
43.82%48.69M
Financial expense
21.15%-37.41M
-21.72%-18.78M
-50.91%-92.98M
-20.18%-62.2M
-135.30%-47.44M
-352.72%-15.43M
-1,285.91%-61.61M
-5,230.01%-51.75M
-1,496.55%-20.16M
486.46%6.11M
-Interest expense (Financial expense)
-17.94%3.21M
-14.54%1.73M
-10.55%6.86M
2.17%5.9M
-17.84%3.91M
-20.03%2.02M
34.77%7.67M
82.76%5.77M
159.91%4.76M
731.91%2.53M
-Interest Income (Financial expense)
3.37%-39.8M
3.08%-20.67M
-108.72%-87.98M
-175.13%-59.7M
-355.33%-41.19M
-993.65%-21.33M
-331.36%-42.15M
-192.73%-21.7M
-261.80%-9.05M
-40.50%-1.95M
Research and development
3.56%479.93M
-5.10%206.73M
9.00%1.2B
114.03%812.68M
98.64%463.43M
104.91%217.84M
61.19%1.1B
-16.25%379.7M
14.13%233.31M
35.79%106.31M
Credit Impairment Loss
31.43%-32.73M
49.63%-35.02M
124.83%22.55M
79.15%-21.55M
50.15%-47.73M
15.84%-69.53M
-8.85%-90.8M
-60.38%-103.32M
-262.82%-95.74M
-496.06%-82.61M
Asset Impairment Loss
48.37%-17.05M
23.57%-9.16M
-2,142.32%-459.73M
-26.93%-29.76M
-87.91%-33.04M
-671.65%-11.98M
31.29%-20.5M
29.06%-23.44M
-167.46%-17.58M
46.73%-1.55M
Other net revenue
1,173.79%195.93M
258.16%47.6M
-245.26%-230.61M
1,431.35%111.76M
126.36%15.38M
53.37%-30.1M
994.02%158.76M
84.88%-8.39M
-2,958.87%-58.36M
-838.23%-64.55M
Fair value change income
-30.47%8.55M
-27.68%3.98M
147.13%24.66M
338.92%17.09M
2,975.63%12.3M
1,735.73%5.51M
35,565.87%9.98M
5,173.14%3.89M
3,735.35%400K
2,776.51%300K
Invest income
96.00%65.97M
242.27%41.53M
173.86%98.9M
425.91%81.2M
497.62%33.66M
395.47%12.13M
221.72%36.11M
78.99%15.44M
9.15%5.63M
-11.72%2.45M
Asset deal income
-66.42%102.26K
----
270.40%221.62K
850.31%176.23K
199.53%304.51K
-111.94%-12.14K
108.29%59.83K
102.25%18.54K
177.39%101.66K
15.67%101.66K
Other revenue
243.00%171.09M
36.97%46.27M
-63.02%82.79M
-34.76%64.6M
2.15%49.88M
101.45%33.78M
163.52%223.91M
190.58%99.02M
62.97%48.83M
138.78%16.77M
Operating profit
-85.92%272.58M
-91.08%127.92M
-74.96%1.4B
-57.42%2B
-40.56%1.94B
-12.14%1.43B
140.33%5.6B
244.71%4.71B
296.24%3.26B
384.52%1.63B
Add:Non operating Income
-90.08%137.22K
-97.04%62.17K
98.14%2.29M
70.54%1.83M
114.78%1.38M
63,042.71%2.1M
75.73%1.16M
113.34%1.08M
95.39%643.91K
-84.54%3.32K
Less:Non operating expense
424.69%14.57M
3.59%2.34M
-28.63%10.35M
-0.31%3.98M
26.16%2.78M
297.61%2.26M
191.89%14.5M
508.48%3.99M
311.28%2.2M
866.79%568.94K
Total profit
-86.66%258.15M
-91.24%125.64M
-75.04%1.39B
-57.44%2B
-40.58%1.93B
-12.12%1.43B
140.20%5.58B
244.54%4.71B
296.15%3.26B
384.41%1.63B
Less:Income tax cost
-102.42%-5.45M
-102.29%-4.14M
-79.58%146.89M
-71.35%191M
-52.71%225.33M
-26.07%180.69M
193.71%719.39M
337.84%666.74M
408.19%476.48M
425.09%244.4M
Net profit
-84.58%263.6M
-89.64%129.78M
-74.37%1.25B
-55.15%1.81B
-38.50%1.71B
-9.66%1.25B
133.90%4.86B
232.83%4.04B
281.73%2.78B
377.88%1.39B
Net profit from continuing operation
-84.58%263.6M
-89.64%129.78M
-74.37%1.25B
-55.15%1.81B
-38.50%1.71B
-9.66%1.25B
133.90%4.86B
232.83%4.04B
281.73%2.78B
377.88%1.39B
Less:Minority Profit
-55.30%3.12M
-47.91%4.08M
-100.92%-1.18M
-96.44%3.4M
-91.92%6.97M
-85.99%7.82M
120.80%127.51M
275.52%95.5M
1,215.16%86.29M
5,646.18%55.86M
Net profit of parent company owners
-84.70%260.48M
-89.90%125.71M
-73.65%1.25B
-54.15%1.81B
-36.78%1.7B
-6.46%1.24B
134.28%4.74B
231.91%3.94B
273.24%2.69B
360.18%1.33B
Earning per share
Basic earning per share
-84.33%0.21
-89.90%0.1
-73.88%0.99
-54.89%1.43
-38.81%1.34
-34.44%0.99
64.78%3.79
134.81%3.17
167.07%2.19
214.58%1.51
Diluted earning per share
-84.33%0.21
-89.90%0.1
-73.88%0.99
-54.89%1.43
-38.81%1.34
-34.44%0.99
64.78%3.79
134.81%3.17
167.07%2.19
214.58%1.51
Other composite income
Total composite income
-84.58%263.6M
-89.64%129.78M
-74.37%1.25B
-55.15%1.81B
-38.50%1.71B
-9.66%1.25B
133.90%4.86B
232.83%4.04B
281.73%2.78B
377.88%1.39B
Total composite income of parent company owners
-84.70%260.48M
-89.90%125.71M
-73.65%1.25B
-54.15%1.81B
-36.78%1.7B
-6.46%1.24B
134.28%4.74B
231.91%3.94B
273.24%2.69B
360.18%1.33B
Total composite income of minority owners
-55.30%3.12M
-47.91%4.08M
-100.92%-1.18M
-96.44%3.4M
-91.92%6.97M
-85.99%7.82M
120.80%127.51M
275.52%95.5M
1,215.16%86.29M
5,646.18%55.86M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Rong Shing Certified Public Accountants (Special General Partnership)
--
--
--
Rong Shing Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue -67.19%1.37B-73.93%752.51M-50.73%5.51B-42.56%4.97B-29.78%4.16B-8.98%2.89B94.51%11.19B140.56%8.65B201.92%5.93B284.85%3.17B
Operating revenue -67.19%1.37B-73.93%752.51M-50.73%5.51B-42.56%4.97B-29.78%4.16B-8.98%2.89B94.51%11.19B140.56%8.65B201.92%5.93B284.85%3.17B
Other operating revenue -0.20%13.54M-----6.56%17.3M----110.02%13.57M-----61.69%18.52M-----93.43%6.46M----
Total operating cost -42.51%1.29B-52.76%672.2M-32.52%3.88B-21.80%3.08B-14.20%2.24B-3.53%1.42B68.85%5.75B80.88%3.93B128.51%2.61B207.04%1.47B
Operating cost -9.73%366.52M-16.30%202.78M-32.32%792.12M-34.40%591.63M-36.59%406.03M-25.81%242.26M43.13%1.17B80.55%901.85M120.55%640.37M153.82%326.55M
Operating tax surcharges -47.23%11.52M-75.45%2.95M-33.87%33.91M-32.53%25.82M-14.15%21.83M4.28%12.01M91.96%51.28M149.89%38.27M172.66%25.43M254.97%11.52M
Operating expense -75.36%315M-77.58%203.52M-50.98%1.6B-39.91%1.51B-21.77%1.28B-6.98%907.65M92.49%3.25B132.42%2.51B192.29%1.63B310.14%975.78M
Administration expense 27.58%153.84M28.03%75M50.15%352.63M30.92%196.63M19.66%120.59M20.31%58.58M28.90%234.85M20.02%150.19M27.12%100.77M43.82%48.69M
Financial expense 21.15%-37.41M-21.72%-18.78M-50.91%-92.98M-20.18%-62.2M-135.30%-47.44M-352.72%-15.43M-1,285.91%-61.61M-5,230.01%-51.75M-1,496.55%-20.16M486.46%6.11M
-Interest expense (Financial expense) -17.94%3.21M-14.54%1.73M-10.55%6.86M2.17%5.9M-17.84%3.91M-20.03%2.02M34.77%7.67M82.76%5.77M159.91%4.76M731.91%2.53M
-Interest Income (Financial expense) 3.37%-39.8M3.08%-20.67M-108.72%-87.98M-175.13%-59.7M-355.33%-41.19M-993.65%-21.33M-331.36%-42.15M-192.73%-21.7M-261.80%-9.05M-40.50%-1.95M
Research and development 3.56%479.93M-5.10%206.73M9.00%1.2B114.03%812.68M98.64%463.43M104.91%217.84M61.19%1.1B-16.25%379.7M14.13%233.31M35.79%106.31M
Credit Impairment Loss 31.43%-32.73M49.63%-35.02M124.83%22.55M79.15%-21.55M50.15%-47.73M15.84%-69.53M-8.85%-90.8M-60.38%-103.32M-262.82%-95.74M-496.06%-82.61M
Asset Impairment Loss 48.37%-17.05M23.57%-9.16M-2,142.32%-459.73M-26.93%-29.76M-87.91%-33.04M-671.65%-11.98M31.29%-20.5M29.06%-23.44M-167.46%-17.58M46.73%-1.55M
Other net revenue 1,173.79%195.93M258.16%47.6M-245.26%-230.61M1,431.35%111.76M126.36%15.38M53.37%-30.1M994.02%158.76M84.88%-8.39M-2,958.87%-58.36M-838.23%-64.55M
Fair value change income -30.47%8.55M-27.68%3.98M147.13%24.66M338.92%17.09M2,975.63%12.3M1,735.73%5.51M35,565.87%9.98M5,173.14%3.89M3,735.35%400K2,776.51%300K
Invest income 96.00%65.97M242.27%41.53M173.86%98.9M425.91%81.2M497.62%33.66M395.47%12.13M221.72%36.11M78.99%15.44M9.15%5.63M-11.72%2.45M
Asset deal income -66.42%102.26K----270.40%221.62K850.31%176.23K199.53%304.51K-111.94%-12.14K108.29%59.83K102.25%18.54K177.39%101.66K15.67%101.66K
Other revenue 243.00%171.09M36.97%46.27M-63.02%82.79M-34.76%64.6M2.15%49.88M101.45%33.78M163.52%223.91M190.58%99.02M62.97%48.83M138.78%16.77M
Operating profit -85.92%272.58M-91.08%127.92M-74.96%1.4B-57.42%2B-40.56%1.94B-12.14%1.43B140.33%5.6B244.71%4.71B296.24%3.26B384.52%1.63B
Add:Non operating Income -90.08%137.22K-97.04%62.17K98.14%2.29M70.54%1.83M114.78%1.38M63,042.71%2.1M75.73%1.16M113.34%1.08M95.39%643.91K-84.54%3.32K
Less:Non operating expense 424.69%14.57M3.59%2.34M-28.63%10.35M-0.31%3.98M26.16%2.78M297.61%2.26M191.89%14.5M508.48%3.99M311.28%2.2M866.79%568.94K
Total profit -86.66%258.15M-91.24%125.64M-75.04%1.39B-57.44%2B-40.58%1.93B-12.12%1.43B140.20%5.58B244.54%4.71B296.15%3.26B384.41%1.63B
Less:Income tax cost -102.42%-5.45M-102.29%-4.14M-79.58%146.89M-71.35%191M-52.71%225.33M-26.07%180.69M193.71%719.39M337.84%666.74M408.19%476.48M425.09%244.4M
Net profit -84.58%263.6M-89.64%129.78M-74.37%1.25B-55.15%1.81B-38.50%1.71B-9.66%1.25B133.90%4.86B232.83%4.04B281.73%2.78B377.88%1.39B
Net profit from continuing operation -84.58%263.6M-89.64%129.78M-74.37%1.25B-55.15%1.81B-38.50%1.71B-9.66%1.25B133.90%4.86B232.83%4.04B281.73%2.78B377.88%1.39B
Less:Minority Profit -55.30%3.12M-47.91%4.08M-100.92%-1.18M-96.44%3.4M-91.92%6.97M-85.99%7.82M120.80%127.51M275.52%95.5M1,215.16%86.29M5,646.18%55.86M
Net profit of parent company owners -84.70%260.48M-89.90%125.71M-73.65%1.25B-54.15%1.81B-36.78%1.7B-6.46%1.24B134.28%4.74B231.91%3.94B273.24%2.69B360.18%1.33B
Earning per share
Basic earning per share -84.33%0.21-89.90%0.1-73.88%0.99-54.89%1.43-38.81%1.34-34.44%0.9964.78%3.79134.81%3.17167.07%2.19214.58%1.51
Diluted earning per share -84.33%0.21-89.90%0.1-73.88%0.99-54.89%1.43-38.81%1.34-34.44%0.9964.78%3.79134.81%3.17167.07%2.19214.58%1.51
Other composite income
Total composite income -84.58%263.6M-89.64%129.78M-74.37%1.25B-55.15%1.81B-38.50%1.71B-9.66%1.25B133.90%4.86B232.83%4.04B281.73%2.78B377.88%1.39B
Total composite income of parent company owners -84.70%260.48M-89.90%125.71M-73.65%1.25B-54.15%1.81B-36.78%1.7B-6.46%1.24B134.28%4.74B231.91%3.94B273.24%2.69B360.18%1.33B
Total composite income of minority owners -55.30%3.12M-47.91%4.08M-100.92%-1.18M-96.44%3.4M-91.92%6.97M-85.99%7.82M120.80%127.51M275.52%95.5M1,215.16%86.29M5,646.18%55.86M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Rong Shing Certified Public Accountants (Special General Partnership)------Rong Shing Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data